PRTA Q1 2020 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$141,000-24.2% YoY

Gross Profit

-$15M-10714.2% margin

Operating Income

-$25M-17622.7% margin

Net Income

-$24M-16715.6% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

-44.9%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$399M

Total Liabilities

$144M

Stockholders' Equity

$255M

Cash & Equivalents

$353M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141,000	$186,000	-24.2%
Gross Profit	-$15M	-$13M	-15.2%
Operating Income	-$25M	-$23M	-8.3%
Net Income	-$24M	-$21M	-13.0%